A model of clinical endometritis in Holstein heifers using pathogenic Escherichia coli and Trueperella pyogenes by Martin, Sheldon
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in:
Journal of Dairy Science
                                    
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa48611
_____________________________________________________________
 
Paper:
Piersanti, R., Zimpel, R., Molinari, P., Dickson, M., Ma, Z., Jeong, K., Santos, J., Sheldon, I. & Bromfield, J. (2019).  A
model of clinical endometritis in Holstein heifers using pathogenic Escherichia coli and Trueperella pyogenes. Journal
of Dairy Science
http://dx.doi.org/10.3168/jds.2018-15595
 
 
 
 
 
 
 
_____________________________________________________________
  
This item is brought to you by Swansea University. Any person downloading material is agreeing to abide by the terms
of the repository licence. Copies of full text items may be used or reproduced in any format or medium, without prior
permission for personal research or study, educational or non-commercial purposes only. The copyright for any work
remains with the original author unless otherwise specified. The full-text must not be sold in any format or medium
without the formal permission of the copyright holder.
 
Permission for multiple reproductions should be obtained from the original author.
 
Authors are personally responsible for adhering to copyright and publisher restrictions when uploading content to the
repository.
 
http://www.swansea.ac.uk/library/researchsupport/ris-support/ 
 1  
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Interpretive Summary  
A model of clinical endometritis in Holstein heifers using pathogenic Escherichia coli and Trueperella 
pyogenes. Piersanti et al. Clinical endometritis is common in postpartum dairy cows and is important because it 
reduces reproductive success, even following resolution of disease. However, it is difficult to disentangle 
mechanisms linking infertility with clinical endometritis because of multiple confounding factors, such as 
periparturient problems and metabolic stress. Here, we developed an experimental model of clinical endometritis 
in virgin Holstein heifers using pathogenic bacteria, which recapitulates the signs of disease, with an active 
infection of the uterus and vaginal discharge of pus. This model will allow exploration of the effects of uterine 
disease on fertility in a controlled animal model system.  
ABSTRACT  
Bacterial infection of the uterus causes clinical endometritis in 15 to 20% of postpartum dairy cows and reduces 
fertility, even after the resolution of disease. However, it is difficult to disentangle the mechanisms linking 
reduced fertility with endometritis because cows have multiple confounding postpartum conditions. The aim of 
the present experiment was to develop an in vivo model of clinical endometritis in Holstein heifers using 
pathogenic Escherichia coli and Trueperella pyogenes. Estrous cycles of heifers were synchronized using a 5-d 
Co-synch protocol, and subsequently received exogenous progesterone to elevate circulating progesterone at the 
time of uterine infusion. Endometrial scarification was performed before uterine infusion of live pathogenic 
Escherichia coli and Trueperella pyogenes, or sterile vehicle. Effects of infusion were evaluated by measuring 
rectal temperature, plasma haptoglobin, hematology, grading pus in the vaginal mucus, quantifying 16S rRNA in 
vaginal mucus, and transrectal ultrasonography. Bacterial infusion increased the median vaginal mucus to grade 
2 by d 3 post-infusion, and to grade 3 from d 4 to 6 post-infusion. Control heifers maintained a median vaginal 
mucus grade ≤ 1 from d 1 to 6. Transrectal ultrasound revealed the accumulation of echogenic fluid in the uterus 
of heifers following bacterial infusion which was absent in control heifers. Total 16S rRNA in vaginal mucus 
was elevated in bacteria infused heifers compared to control heifers at d 5. Rectal temperature was increased in 
bacteria infused heifers. Plasma haptoglobin, general health, and appetite did not differ between groups. As 
indicated by increased vaginal mucus grade after bacterial infusion and absence of systemic signs of illness, this 
model successfully induced symptoms resembling clinical endometritis in virgin Holstein heifers. The model 
allows the isolation of effects of uterine disease on fertility from confounding factors that can occur during the 
postpartum period in dairy cows.  
Keywords: animal model, dairy cow, clinical endometritis, inflammation, uterine infection.  
INTRODUCTION  
Clinical endometritis is characterized by inflammation resulting from bacterial infection of the 
endometrium that causes a purulent uterine discharge that is present 21 d or more postpartum. Endometritis has a 
lactation incidence of 15 to 20%, and is important because, even after resolution of the clinical signs, cows have 
delayed conception and are more likely to be culled for reproductive failure than cows without endometritis 
(LeBlanc et al., 2002, Gernand et al., 2012, Ribeiro et al., 2013). However, understanding how uterine disease 
affects fertility is complicated because endometritis is associated with other peripartum problems as well as 
metabolic challenges associated with the onset of lactation, which also impair fertility (LeBlanc, 2012, Ribeiro 
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et al., 2013). Developing an experimental model of clinical endometritis in heifers would help disentangle the 
mechanisms of how uterine disease impacts reproductive physiology.  
Cows with clinical endometritis do not have systemic signs of disease, and diagnosis is based on the 
presence of a purulent uterine discharge detectable in the vagina 21 d or more postpartum (LeBlanc et al., 2002, 
Sheldon et al., 2006). The vaginal contents can be examined using a gloved hand, a Metricheck tool or a 
speculum, and the severity of clinical endometritis can be graded by the amount of pus in the mucus. There is 
debate about whether purulent vaginal discharge may also reflect cervicitis or vaginitis because not all cows 
with purulent vaginal discharge have infiltration of polymorphonuclear neutrophils detectable by endometrial 
cytology (Dubuc et al., 2010). Nevertheless, bacteria can be isolated from the uterus of cows with endometritis, 
and the presence of pus in the uterus or a slightly enlarged uterus can also be visualized using transrectal 
ultrasonography (Sheldon et al., 2002).   
Clinical endometritis is associated with Gram-negative endometrial pathogenic Escherichia coli, 
Grampositive Trueperella pyogenes, and several anaerobes (Sheldon et al., 2002, Bicalho et al., 2012). Both E. 
coli and T. pyogenes can be detected in the uterus of cows that develop uterine disease as early as 1 to 3 DIM 
based on culture and PCR based technologies (Dohmen et al., 2000, Bicalho et al., 2012). Lipopolysaccharide 
(LPS) from Gram-negative bacteria and lipopeptides from Gram-positive bacteria activate the innate immune 
system in the endometrium, leading to inflammation and increased concentrations of circulating acute phase 
proteins (Sheldon et al., 2001, LeBlanc, 2012, Turner et al., 2014). Pus forms in the uterus when neutrophils 
phagocytize bacteria or endometrial cells damaged by cytolysins, such as the pore-forming toxin pyolysin 
secreted by T. pyogenes (Sheldon et al., 2010, Bicalho et al., 2012, Amos et al., 2014). A notable feature of the 
pathogenesis of endometritis is that the adhesion of E. coli to endometrial cells and the cytolysis caused by 
pyolysin is greatest in the stroma, which is exposed when the epithelium is lost during the peripartum period 
(Sheldon et al., 2010, Amos et al., 2014). Furthermore, peripartum problems that traumatize the endometrium, 
such as dystocia and retained fetal membranes, increase the risk of developing endometritis (Dubuc et al., 2010, 
Potter et al., 2010, Ribeiro et al., 2013).   
Uterine disease is associated with prolonged luteal phases, slowed rate of growth of ovarian follicles 
postpartum, and impaired ovarian endocrine function (Opsomer et al., 2000, Sheldon et al., 2002). However, the 
mechanisms linking endometritis with reproduction are not fully established because fertility is also perturbed 
by many of the risk factors for endometritis, including peripartum problems and the inability to adapt to the 
shifts in metabolism to accommodate lactation (Chagas et al., 2007, LeBlanc, 2012). Animal models of clinical 
endometritis have been reported using mature cows infused with T. pyogenes (Rowson et al., 1953, Ayliffe and 
Noakes, 1982, Farin et al., 1989, Amos et al., 2014). However, an experimental model of endometritis in heifers 
would be attractive for exploring how uterine infection affects reproduction. Using heifers as the basis for the 
model circumvents many of the confounding effects of parturition and lactation observed in lactating cows. The 
aim of the present experiment was to develop a defined in vivo infection model of clinical endometritis in 
Holstein heifers using pathogenic E. coli and T. pyogenes.  
MATERIALS AND METHODS  
The University of Florida Institutional Animal Care and Use Committee approved all procedures with 
heifers under the protocol number 201508884. The experiment was conducted from June to October, 2017 at the 
University of Florida Dairy Unit.   
Establishment of Uterine Infection in Heifers  
Nine virgin Holstein heifers aged between 11 and 13 months were enrolled in the experiment. All animals were 
free of general health conditions and tested negative for Brucella abortus, Neospora caninum, and Leptospirosa. 
Heifers were vaccinated against bovine viral diarrhea, infectious bovine rinotracheitis, parainfluenza, bovine 
respiratory syncytial virus, and multiple serovars of Leptospira (Bovi-Shield Gold FP 5 VL5 HB; Zoetis, 
Parsippany NJ) and de-wormed using moxidectin (Cydectin; Bayer HealthCare, LLC, Animal Health Division, 
Shawnee Mission, KS). Heifers were fed a diet as TMR that was offered once a day in addition to pasture access 
and provided ad libitum access to water.   
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The experiment followed a randomized complete block design with heifer as the experimental unit. Heifers 
were blocked by age and weight, and randomly assigned to one of two infusion treatments: intra-uterine infusion 
of sterile vehicle medium alone (n = 5) or intra-uterine infusion of live bacteria (n = 4; details below).   
Estrous cycles were synchronized using a modified 5-d Co-synch protocol (Lima et al., 2013). Briefly, 
heifers received 100 mg i.m. of GnRH (gonadorelin diacetate tetrahydrate; Ovacyst, Bayer) followed by 25 mg  
i.m. of PGF2α (dinoprost tromethamine; Prostamate, Bayer) administered 5 and 6 d later (Figure 1A). Eight days 
following initial GnRH, heifers received a final dose of 100 mg of GnRH i.m. Starting on the day following the 
final GnRH, heifers received 200 mg i.m. of progesterone (P4) in corn oil (50 mg/mL; Sigma-Aldrich, St Louis 
MO) daily for 7 d. Exogenous P4 was administered to mimic diestrus and ensure elevated circulating P4 at the 
time of bacterial infusion.  
Uterine infusion of treatments were performed 72 h following final GnRH administration and designated as 
d 0 relative to treatment (Figure 1A). Endometrial scarification was implemented before intra-uterine infusion to 
disrupt the endometrial epithelium. Heifers were restrained and received a caudal epidural injection of 60 mg of 
lidocaine hydrochloride 2% (Aspen Veterinary Resources, Greely CO). The perineum and vulva were cleaned 
and disinfected with povidone iodine followed by 70% ethanol, and a sterile metal scarification tool enclosed by 
a metal catheter covered in a sanitary sheath (IMV Technologies, Normandy, France) was introduced through 
the vagina and cervix. The scarification tool consisted of a stainless steel rod with a 39 mm long, 6 mm diameter 
threaded component on the tip, similar to a threaded bolt (Figure 1B). The scarification tool was manipulated 
through the cervix and into the body of the uterus by transrectal palpation. Once inside the body of the uterus, 
the sanitary sheath was retracted, and the scarification tool was placed in direct contact with the endometrium. 
The scarification tool was then rotated once to disrupt the endometrial lining before removal from the 
reproductive tract. Inspection of the scarification tool upon retraction confirmed tissue disruption by the 
presence of small pieces of tissue. Following endometrial scarification, a metal infusion catheter enclosed in a 
sanitary sheath was introduced transcervically into the body of the uterus. The sanitary sheath was retracted, and 
treatments were infused using 10 mL syringes. Bacterial infusion consisted of 10 mL of 4.64 × 107 CFU/mL of 
E. coli MS499, 10 mL of 3.38 × 107 CFU/mL T. pyogenes MS249 followed by 10 mL of sterile Luria-Bertani 
(LB) broth to flush the catheter (Goldstone et al., 2014a, Goldstone et al., 2014b). Vehicle infusion consisted of 
30 mL of LB broth. Heifers were returned to pasture and monitored for clinical signs for 24 h. Animals did not 
receive any additional treatments or medication during the experimental period.  
Bacterial Culture and Preparation of Inoculants  
Escherichia coli MS499 and T. pyogenes MS249 were collected and isolated from cows with metritis and 
characterized previously (Goldstone et al., 2014a, Goldstone et al., 2014b).  
Escherichia coli was cultured from frozen glycerol stocks on LB agar. The day before infusion, a single 
colony was picked from the plate and inoculated into LB broth containing 1% tryptone, 0.5% yeast extract and 
1% sodium chloride. The culture was incubated overnight at 37°C with shaking at 200 rpm. Growth was 
monitored by measuring optical density at 600 nm (OD600 = 5.0). A final preparation of 4.64 × 107 CFU/mL E. 
coli was diluted in sterile LB broth and loaded into 10 mL syringes for infusion.   
Trueperella pyogenes MS249 was grown from frozen glycerol stocks on Trypticase Soy Blood agar and 
grown at 37°C for 48 h. The day before infusion, a single colony was selected and inoculated into Bacto Brain  
Heart Infusion broth (BHI; Fisher Scientific, Pittsburg, PA) supplemented with 5% fetal bovine serum (FBS; 
Fisher Scientific) and cultured overnight at 37°C with shaking at 200 rpm. Growth was monitored by measuring 
optical density at 600 nm (OD600 = 0.2). A final preparation of 3.38 × 107 CFU/mL T. pyogenes was diluted in 
sterile BHI and loaded into 10 mL syringes for infusion. Syringes were loaded with sterile LB broth for flushing 
catheters and vehicle infusions. Inoculants were transported to the farm on ice for infusion.  
Blood Sampling and Hematology   
Blood was collected from the coccygeal vessels into evacuated tubes (Vacutainer, Becton Dickson, 
Franklin Lakes NJ) containing sodium heparin for plasma separation or potassium EDTA for hematology. Blood 
was sampled every other day from d -2 to 18 relative to treatment. Blood was placed on ice until further 
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processing. Tubes containing heparin were centrifuged and plasma was collected, aliquoted, and stored at -20°C. 
Whole blood was transported to the laboratory on ice within 2 h of collection and used for hematology analysis 
performed using an automated hematology analyzer (ProCyte Dx Hematology Analyzer, IDEXX Laboratories, 
Westbrook ME). Hematology analysis included total and differential leukocyte counts (neutrophils, 
lymphocytes, and eosinophils), red blood cells, hematocrit and hemoglobin. Hematology was evaluated on d -1, 
1, 3 and 7 relative to treatment (Figure 1A).  
Plasma haptoglobin (Life Diagnostics, Inc., West Chester, PA) and P4 (DRG International, Inc., 
Springfield, NJ) were measured using commercially available ELISA according to the manufacturer’s  
instructions. Plasma haptoglobin was evaluated on d 0, 7 and 13 relative to treatment, and P4 was evaluated on d 
-2, 1, 4, 11 and 17 relative to treatment (Figure 1A). The P4 ELISA is human specific and was validated for 
bovine plasma using spike-in/recovery performance based on actual and expected recovery of P4 supplied as 
standard with the kit. Intra-assay CV was calculated at 6.5%, while recovery of spike-in P4 was 89% to 101.8% 
of expected P4.   
Examination and Grading of Vaginal Mucus, Transrectal Ultrasonography, and Rectal Temperature  
Vaginal mucus was collected and examined using a clean Metricheck tool (Metricheck, Simcro, New 
Zealand). Vaginal mucus was scored as grade 0, no mucus or clear or translucent mucus; grade 1, mucus 
containing flecks of white or off-white pus; grade 2, mucus containing ≤ 50% white or off-white mucopurulent 
material; and grade 3, mucus containing > 50% purulent material (Sheldon et al., 2009). Evaluation of vaginal 
mucus was performed daily from d -1 to 7 relative to treatment (Figures 2A-C).  
Transrectal ultrasonography with a linear 5.0 MHz probe (Aloka SSD-500, Hitachi Healthcare Americas, 
Twinsburg, OH) was performed to visualize fluid and pus in the uterus. Ultrasonography was performed every 
other day from d -1 to d 10 relative to treatment. Rectal temperature (AG-102 thermometer, AG-Medix, 
Mukwonago WI) was measured daily between 7 and 9 AM from d -11 to 10 relative to treatment. A rectal 
temperature of > 39.5°C was classified as fever.  
Quantification of Total 16S rRNA Isolated From Vaginal Mucus  
Vaginal mucus was stored in sterile bijou bottles at -20°C until processing. Total DNA was isolated from 
vaginal mucus using the DNeasy Power Soil Kit according to the manufacturer’s instruction with modification 
(Qiagen, Hilden, Germany). Briefly, samples were thawed on ice and vortexed and 250 mg of vaginal mucus 
was used for DNA extraction using a bead beater tissue homogenizer (Precellys 24, Bertin Technologies SAS, 
France). The mucus was added to guanidine thiocyanate and homogenized with garnet particles using 3 bead 
beater cycles (30 s at 6000 × g, 60 s pause, 30 s at 6000 × g) with a 5 min incubation on ice between each cycle. 
Following homogenization, supernatants were applied to the DNeasy Power Soil spin columns for DNA 
purification.  
Total 16S rRNA was quantified using the Femto Bacterial DNA Quantification Kit according to the 
manufacturer’s instructions (Zymo Research, Irvine CA). Thermocycling conditions included initial 
denaturation at 95°C for 10 min, 40 cycles of amplification consisting of denaturation at 95°C for 30 s, 
annealing at 50°C for 30 s and extension at 72°C for 1 min, followed by a final extension at 72°C for 7 min. A 
total of 2 μL of extracted total DNA sample was applied to each PCR reaction. Quantification of 16S rRNA was 
analyzed based on a standard curve performed in parallel with mucus samples. Data for total 16S rRNA are 
described as nanograms of 16S rRNA per milligram of vaginal mucus. The extraction of 16S rRNA in mucus 
samples was validated using spike-in/recovery using of using known quantities of purified bacteria. Intra-assay 
CV was calculated at 0.3%, inter-assay CV was calculated at 2.2%, while recovery of 16S rRNA following 
extraction of bacteria spike-in pus was 100.5% of expected 16S rRNA content.  
Statistical Analysis  
All data were analyzed using SAS v. 9.4 (SAS Institute, Cary, NC). Vaginal mucus grade was reported as 
the median for each treatment group and analyzed using the GLIMMIX procedure following a Poisson 
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distribution. Cow within treatment was considered a random effect, and fixed effects of treatment and day were 
analyzed. Haptoglobin, P4, hematology and DNA concentration for the 16S rRNA gene were analyzed using the 
MIXED procedure of SAS and the models included the fixed effects of treatment (bacterial infusion), day  
(repeated measure), and their interaction. Heifer nested within treatment was considered as a random effect. First 
order autoregressive covariance structure AR (1) was used as the covariate structure. Values are reported as 
LSM ± SEM. Differences with P ≤ 0.05 were considered statistically significant.  
RESULTS   
Intra-Uterine Bacterial Infusion Increased Vaginal Mucus Grade  
Vaginal discharge of pus was visually evident in heifers that were infused with live bacteria, but not in 
control heifers (Figure 2A). Vaginal mucus collected by Metricheck was graded and compared between 
treatments (Figure 2B-C). There was an increase (P < 0.02) in the vaginal mucus grade of heifers treated with 
bacteria (Figure 3). Heifers in both infusion groups had a median mucus grade of 0 prior to uterine infusion 
(Figure 3). Intra-uterine infusion of live bacteria resulted in a median mucus grade of 2 on d 3 relative to 
treatment, whereas control heifers maintained a median mucus grade of 0 (Figure 3). On d 4 to 6 relative to 
treatment, bacteria infused heifers had a median mucus grade of 3, whereas control heifers presented a median 
mucus grade ≤ 1. The presence of echogenic fluid in the uterus of bacterial infused heifers was confirmed by 
transrectal ultrasound, and control heifers had no evidence of increased fluid, or echogenic material present in 
the uterus (Figure 2D-E).  
Intra-Uterine Bacterial Infusion Increased 16S rRNA Concentration in Vaginal Mucus  
Total vaginal 16S rRNA was increased (P < 0.05) in bacteria infused heifers compared with control heifers 
on d 5 (Figure 4A). In addition, total vaginal 16S rRNA was greater (P < 0.05) on d 5 in heifers infused with 
bacteria compared to other sampled days (Figure 4A). There was no interaction between treatment and day 
relative to treatment (P = 0.14).  
Effect of Uterine Bacterial Infusion on Hematology and Rectal Temperature  
There was no effect of treatment on any hematological parameters measured (Table 1). There was an effect 
(P < 0.05) of day relative to treatment on the number of red blood cells (M/ μL), number of lymphocytes 
(K/μL), number of platelets (K/μL), percent of hematocrit and hemoglobin (g/dL). There was a tendency for an 
effect of treatment (P = 0.08) on rectal temperature with bacteria infused heifers showing elevated temperature 
on d 1 compared to control heifers (Table 1). Two bacteria infused heifers had rectal temperatures above 39.5°C 
on d 1 relative to treatment (40.0°C and 40.2°C). There were no overt signs of systemic disease observed in any 
heifers.  
  
Effect of Bacterial Infusion on Circulating Concentrations of Haptoglobin and Progesterone in Plasma   
Plasma concentration of haptoglobin did not differ (P = 0.70) between treatments and there was no effect 
of day (P = 0.36) or interaction between day and treatment (P = 0.41). A numerical 3.5-fold increase in 
haptoglobin concentration on d 13 relative to treatment was observed in bacteria infused heifers compared with 
control heifers (Figure 4B; P > 0.05).  
Plasma concentrations of P4 increased in both treatment groups as a result of exogenous P4 
supplementation (effect of day, P < 0.001); however, infusion with bacterial did not affect concentrations of P4 
in plasma (P > 0.05, Figure 4C). The peak concentration was observed on d 4 relative to treatment and, once 
exogenous P4 supplementation was concluded on d 4, concentrations decreased in both treatments.   
DISCUSSION  
The present experiment developed an in vivo model of clinical endometritis in Holstein heifers using 
pathogenic E. coli and T. pyogenes. Heifers that received intra-uterine infusion of pathogenic bacteria developed 
purulent vaginal mucus, accumulation of echogenic fluid in the uterus, and increased bacterial load in vaginal 
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mucus. In parallel, bacteria infused heifers displayed no systemic signs of illness, such as altered hematology or 
general sickness. Control heifers did not display any of the clinical signs of clinical endometritis. Based on the 
criteria previously described for the disease, these results recapitulate the symptoms of clinical endometritis 
observed in the postpartum dairy cow (LeBlanc et al., 2002, Sheldon et al., 2006, Sheldon et al., 2009).  
Previous experimental models of clinical endometritis have focused on the use of mature cows and 
intrauterine infusion of T. pyogenes (Rowson et al., 1953, Ayliffe and Noakes, 1982, Amos et al., 2014). These 
studies were capable of generating active infection of the uterus, evident by the presence of mucopurulent 
vaginal contents, using a single uterine pathogen. Although these models induce clinical symptoms of disease, it 
may be that the use of a second pathogen, E. coli, better reflects the molecular profile of endometritis to evaluate 
the consequences of disease on fertility. The dual pathogen model of Del Vecchio et al. (1992) utilized repeated 
infusions of both E. coli and T. pyogenes over the course of 3 d (Del Vecchio et al., 1992); however, the strain  
and pathogenicity of bacteria used may also be important. Strains used by others include β-hemolytic E. coli or 
T. pyogenes sourced from cows with severe endometritis (presumably from the uterus). Additionally, Farin et 
al., (1989) utilized intra-uterine infusion of T. pyogenes and the Gram-negative anaerobes, Fusobacterium 
necrophorum and Bacteroides melaninogenicus (now Prevotella melaninogenica) to induce “pyometria” in 
lactating multiparous cows. The model describes the implementation of tissue damage using an intrauterine 
infusion of iodine solution, and intravenous administration of hCG to ensure elevated circulating P4, two factors 
recapitulated in our model but using different approaches. The model of Farin et al., (1989) also reports the 
consistent isolation and culture of uterine T. pyogenes during an extended window of active disease lasting up to 
30 d post-infusion in some cows. The presence of E. coli was not reported in these studies, while isolation and 
culture of the anaerobes, F. necrophorum and P. melaninogenica, was inconsistent between cows with disease 
(Farin et al., 1989). Pathogenic strains of E. coli and T. pyogenes used in the current model were sourced from 
the uterus of cows with endometritis and have subsequently been sequenced (Goldstone et al., 2014a, Goldstone 
et al., 2014b), allowing a detailed understanding of virulence factors and host-pathogen interactions involved in 
disease. These two species of pathogens were specifically chosen to establish infection as they are readily 
detectable within days of parturition in the uterus of cows that develop spontaneous uterine disease (Dohmen et 
al., 2000, Bicalho et al., 2012). The pore forming toxin produced by T. pyogenes causes cellular damage to the 
endometrium during active infection, although little is known about its actions on ovarian function, especially 
after the clearance of disease. Conversely, LPS derived from Gram-negative bacteria is present in follicular fluid 
after the resolution of uterine disease. Indeed, studies have demonstrated that the presence of LPS negatively 
effects oocyte development and alters the follicular environment of the growing oocyte in vitro (Bromfield and 
Sheldon, 2011).   
Species other than the cow have been used to develop models of uterine infection, including the sheep and 
mouse (Regassa et al., 2002, Sheldon and Roberts, 2010, Bromfield and Sheldon, 2013). However, when 
attempting to determine the mechanisms by which endometritis impacts fertility of the dairy cow, it is 
imperative to utilize the target species in question. Rodents are relatively inexpensive and convenient for such a 
model, but the reproductive physiology and immune function of the mouse is considerably different from those 
of the cow. Mice have been shown to be 1 million-fold less sensitive to LPS than humans (Seok et al., 2013). 
More appropriately, the human and bovine genomes share a high degree of amino acid sequence homology, 
limited species-specific orthologs, and a similar chromosomal organization; suggesting the bovine as a useful 
experimental model for human physiology (The Bovine Genome Sequencing and Analysis Consortium et al., 
2009). In addition, bovine reproductive biology is closer to that of humans than mice; cows and humans are both 
monotocous with similar hormonal profiles over a 3 to 4 week ovarian cycle, compared to the polytocous mouse 
with a 4 d estrous cycle. The current model of endometritis may even serve as a tool to study the impacts of 
uterine infections on human fertility.  
The use of the Holstein heifers in the present experiment was a deliberate choice in the generation of the 
experimental model presented. The long-term goal of this model is to study the mechanisms of endometritis 
mediated reproductive failure in the cow. As uterine disease occurs in the early postpartum period, a number of 
significant challenges can confound experimental investigation into the causes of endometritis-mediated 
infertility. Specifically, postpartum uterine damage, uterine involution, metabolic demands of lactation, negative 
nutrient balance, and additional postpartum illnesses which affect almost half of all postpartum cows (Ribeiro et 
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al., 2016). Retained placenta and dystocia are significant risk factors for the development of endometritis, and 
are both associated with damage to the endometrium (Dubuc et al., 2010). To recapitulate postpartum 
endometrial damage, we performed a scarification procedure to disrupt the endometrial epithelial layer at the 
time of bacterial infusion. This process of scarification may be critical to the establishment of the disease model 
to facilitate bacterial access to the underlying stroma. Previous work has reported differential susceptibility of 
epithelial and stromal endometrial cells to pathogenic E. coli, with pathogenic E. coli binding with stronger 
affinity to stromal cells, and purified LPS inducing a stronger inflammatory reaction in the endometrial stroma 
(Sheldon et al., 2010). A similar phenomenon of differential cellular susceptibility has been described in the 
response of endometrial epithelial and stromal cells to T. pyogenes pyolysin, in which stroma cells are 
considerably more sensitive to the cytoxic effects of pyolysin (Amos et al., 2014), suggesting the stroma is the 
target of pyolysin. These in vitro experiments, in combination with the risk factors associated with endometritis, 
suggest that endometrial scarification may be an important procedure in the establishment of clinical 
endometritis observed in the present model.  
The administration of exogenous P4 was a calculated approach to modulate the immune function of heifers 
at the time of bacterial infusion. Rowson et al. (1953) reported that intra-uterine infusion of T. pyogenes 
(reported as Corynebacterium pyogenes) during the luteal phase of the estrous cycle resulted in “pyometritis”; 
however, no infection could be established when bacterial infusion was performed at estrus. These experiments 
were repeated using ovariectomized cows in conjunction with administration of exogenous P4 or estradiol. Only 
with the administration of exogenous P4 could pyometritis be achieved (Rowson et al., 1953). Since the 1950’s, 
the immune modulating properties of P4 and estrogen have been reported in immune cells and the endometrium 
(reviewed in detail by (Wira et al., 2015)) with various studies demonstrating the immune-suppressive function 
of P4 within the endometrium of ruminants (Hawk et al., 1964, Del Vecchio et al., 1992, Hansen, 1998, Seals et 
al., 2002, Lewis, 2003). The ability of steroid hormones to modulate endometrial immune function have led to 
the practice of administering PGF2α as a treatment for uterine infection to induce luteolysis in cows in diestrus, 
and elevate estrogen by stimulating a new follicular phase of the estrous cycle (Lewis, 1997); however this 
remains debated. In parallel, 55% of cows with metritis display extended luteal phases (Etherington et al., 1991, 
Opsomer et al., 2000). The extension of the luteal phase in cows with uterine disease can have consequences on 
the calving to conception interval, negatively impacting productivity. Exposure of endometrial cells to bacterial 
LPS in vitro switches prostaglandin synthesis from luteolytic PGF2α to luteotrophic PGE2 (Herath et al., 2006, 
Herath et al., 2009). This apparent LPS-mediated switch in endometrial secretion of luteotrophic PGE2 may 
explain the extended luteal phase in some cows with uterine disease. In the current study we evaluated 
circulating P4 until d 18 post-infusion, and did not observe any effect of treatment at any time point. This result 
may be an influence of exogenous P4 administration for 7 consecutive days, or an artifact of the extensive 
manual manipulations performed on these heifers during the course of the study. Future studies using this model 
of induced infection should evaluate the duration of the luteal phase, monitoring follicular growth, ovulation, CL 
size, peak P4 and luteal phase duration.  
Vaginal mucopurelent content observed in heifers treated with intra-uterine infusion containing live 
bacteria could be associated with cervicitis or vaginitis as previously observed in spontaneously occurring cases 
in postpartum cows (Dubuc et al., 2010). Although the infusate was placed in the uterine horns, retrograde 
movement of the content could have inoculated the cervix and vagina. However, quantification of vaginal 16S 
rRNA the day after infusion on experiment d 1 revealed comparable total bacterial load between treatments. The 
presence of elevated 16S rRNA observed in the bacteria infused heifers 5 d following infusion suggests that 
mucopurulent vaginal discharge is derived from the infected uterus induced by infused bacteria, and not from 
environmental contamination. The accumulation of echogenic uterine fluid in bacteria-infused heifers supports 
these assumptions and suggests that any cervicitis or vaginitis would likely be the result of contamination or 
excessive manipulation, and would also be observed in vehicle infused controls. Interestingly however, 
hematological evaluation of heifers suggests a possible effect of the procedure of infusing material into the 
uterus itself. While we did not observe a treatment effect for any of the hematological parameters evaluated, we 
did see an effect of day on numbers of red blood cells, lymphocytes, and platelets, and the percent of hematocrit 
and hemoglobin. Consistently all of these parameters were elevated 24 h following infusion and steadily 
declined to pre-infusion levels by d 7. This observation may be indicative of the manual manipulation effecting 
systemic hematological parameters in the heifers.    
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Any experimental model of infection has limitations. Here, we propose using the described experimental 
model to define the mechanisms of endometritis-mediated subfertility. However, using heifers as the 
experimental unit limits our understanding of the reproductive potential of the individual animal, unlike using 
mature lactating cows that would normally have uterine disease. Additionally, the use of heifers revealed 
experimental limitations because of body size and ability to perform the manipulations in 12 to 13-mo old 
animals, indicated by the consistent day effect of some hematological parameters. Experimentation for the 
purposes of determining mechanisms of endometritis-mediated subfertility will require multiple, repeat 
manipulations which might be difficult in small frame heifers compared with mature cows. The longevity of the 
experimental model is also an important factor to determine in future cohorts of animals, it will be important to 
establish that the infection observed in the current cohort of heifers is reminiscent of the duration of spontaneous 
endometritis observed in lactating cows. Additionally, quantification of endometrial inflammation and microbial 
populations present as a result of experimentally induced infection will be critical to establish the validity of the 
model to study endometritis-mediated subfertility in the dairy cow.  
CONCLUSIONS  
We have successfully created a model of experimentally induced clinical endometritis in virgin Holstein 
heifers. This model will allow the investigation into the mechanisms of endometritis associated reproductive 
failure. The use of an experimental model of endometritis allows investigation into endometritis-mediated 
subfertility independent of confounding postpartum events common in lactating cows which may influence 
reproductive physiology. We utilized a combination of interventions to facilitate uterine infection, including 
disruption of the endometrial epithelial barrier, the supplementation of exogenous P4, and the infusion of uterine 
pathogenic bacteria. We conclude that our experimental model recapitulates clinical endometritis symptoms in 
virgin Holstein heifers.  
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Figure 1. Requirements for establishment of experimental uterine infection. (A) Time line of experimental 
procedures employed during the experimental period. Gonadotropin releasing hormone (GnRH) and 
prostaglandin (PG) F2α were used to synchronize estrous cycles in 9 virgin Holstein heifers before intra-uterine 
infusion of treatments. On d 0, intra-uterine infusion of either vehicle or live bacteria was performed. Vehicle 
infusion consisted of 30 mL of sterile Luria-Bertani broth. Bacteria infusion consisted of 10 mL of E. coli MS  
499 (4.64 × 107 CFU/mL), 10 ml of T. pyogenes MS249 (3.38 × 107 CFU/mL) and 10 mL of sterile LuriaBertani 
broth. P4 was administered at 200 mg/d i.m. Days relative to treatment for evaluation of plasma haptoglobin 
(hpt), P4 (P4) and hematology (hem) are indicated in italics. (B) The tool utilized to enable scarification of the 
endometrium.  
  
  
  
Figure 2. Clinical observations of induced uterine disease. (A) Vaginal mucus was visually confirmed in 
heifers receiving bacterial infusion. (B) Metricheck tool containing vaginal mucus of a bacteria infused heifer. 
(C) Examples of vaginal mucus samples collected from bacteria infused heifers using the Metricheck tool. (D 
and E) Representative ultrasound images of a transverse cross section of a uterine horn from a control (D) and 
bacteria infused (E) heifer. The arrow head denotes the uterine lumen; the double headed arrow denoted the 
uterine wall; scale bar represents 5 mm.  
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Figure 3. Vaginal mucus grade following intra-uterine infusion of bacteria. Vaginal mucus was collected 
using a Metricheck tool and graded according to Sheldon et al. (2009). Vaginal mucus was graded from 0 to 3 
and each heifer is represented by a single circle. Control heifers are represented by open circles (A, ○), bacteria 
infused heifers are represented by filled circles (B, ●). The vertical dotted line denotes the day of treatment, solid 
horizontal lines indicate the median vaginal mucus score for the day of observation. Data were analyzed using 
the GLIMMIX procedure following a Poisson distribution to determine the effect of treatment (Trt).  
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Figure 4. Effect of treatment on vaginal mucus 16S rRNA and circulating concentrations of haptoglobin 
and progesterone in plasma. (A) Total 16S rRNA quantification from vaginal mucus on d -5, -1, 1 and 5 
relative to treatment in either control (open bars) or bacteria infused (solid bars) heifers. Total 16S rRNA was 
normalized to the weight of vaginal mucus processed for nucleic acid extraction (ng rRNA per mg mucus). 
Different superscript denote differences within the bacteria infused group; * denotes difference between 
treatment groups on a given day (P < 0.05). (B) Haptoglobin plasma concentration (ng/mL) was measured in 
control (○) and bacteria infused (●) heifers on d 0, 7 and 13 relative to treatment. (C) Progesterone plasma 
concentration (ng/mL) was measured in control (○) and bacteria infused (●) heifers on d -2, 1, 4, 11 and 15 
relative to treatment. P4 denotes the period of exogenous administration of 200 mg/d of P4. All data are 
presented as LSM ± SEM.   
Table 1. Effect of treatment on rectal temperature and hematology.   
                                                          
1 Data are presented as LSM with respective pooled SEM for the interaction between treatment and day.  
Data quantified in whole blood included red blood cells count (RBC), hematocrit (HCT), hemoglobin concentration (HGB), white blood cells 
count (WBC), neutrophils (NEU), lymphocytes (LYM), monocytes (MON), eosinophils (EOS) and platelets (PLT) measured as the  
proportion of total cells (%) and number of cells per μL (K = 1,000; M = 1,000,000). 3 
Sample days relative to infusion (d -1, 1, 3 and 7).  
  1  38.7  39.5          
  3  38.3  38.7          
  7  38.5  38.5          
RBC (M/μL)  -1  6.78  6.36  0.31  0.3  <0.01  0.85  
  1  7.79  7.03          
  3  7.37  6.75          
  7  7.17  6.70          
HCT (%)  -1  30.04  29.60  1.50  0.68  <0.01  0.81  
  1  33.70  32.80          
  3  33.04  31.43          
  7  32.34  31.73          
HGB (g/dL)  -1  10.20  9.93  0.51  0.65  <0.01  0.96  
  1  11.24  10.98          
  3  11.00  10.55          
  7  10.80  10.43          
WBC (K/μL)  -1  12.12  11.72  0.85  0.65  0.45  0.86  
  1  12.31  12.81          
  3  10.38  11.43          
14  
  
 TRT  Day  
 -1  0.08   0.01  
                                                          
1 TRT = effect of treatment (control vs. bacteria); Day = effect of day relative to treatment; TRT × day = interaction between TRT and Day.  
  7  10.96  12.08          
NEU (%)  -1  30.86  22.33  3.47  0.34  0.34  0.28  
  1  24.82  19.18          
  3  24.18  13.56          
  7  19.24  24.08          
NEU (K/μL)  -1  3.88  2.72  0.59  0.66  0.23  0.22  
  1  3.06  2.58          
  3  2.53  1.42          
  7  1.94  3.19          
LYM (%)  -1  44.24  54.38  4.64  0.70  0.27  0.11  
  1  50.12  58.35          
  3  50.98  51.23          
  7  60.80  52.70          
LYM (K/μL)  -1  5.20  6.25  0.43  0.29  0.59  0.51  
  1  6.14  7.35          
  3  5.33  6.64          
  7  6.89  6.07          
MON (%)  -1  17.44  16.95  1.88  0.52  0.27  0.37  
  1  18.32  14.93          
  3  18.00  26.60          
  7  14.32  17.18          
MON (K/μL)  -1  2.13  1.95  0.20  0.84  0.32  0.47  
  1  2.28  2.18          
  3  1.83  1.84          
  7  1.59  2.11          
EOS (%)  -1  7.42  6.30  1.00  0.86  0.13  0.27  
  1  6.68  5.50          
  3  6.80  9.18          
  7  5.01  6.03          
EOS (K/μL)  -1  0.91  0.80  0.15  0.85  0.14  0.20  
  1  0.81  0.69          
  3  0.70  0.92          
  7  0.53  0.72          
PLT (K/μL)  -1  312.2  241.00  68.98  0.45   < 0.01  0.82  
  1  380.00  261.00          
  3  318.20  221.00          
  7  146.20  117.75          
  Treatment     P - value 1   
Variable 2   Days 3   Control   Bacteria   SEM   Trt  ×   day   
Temp   ( °C )   38.4   38.3   0.1   0.19   
